Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion gene.
Walz C, Curtis C, Schnittger S, Schultheis B, Metzgeroth G, Schoch C, Lengfelder E, Erben P, Müller MC, Haferlach T, Hochhaus A, Hehlmann R, Cross NC, Reiter A. Walz C, et al. Among authors: schultheis b. Genes Chromosomes Cancer. 2006 Oct;45(10):950-6. doi: 10.1002/gcc.20359. Genes Chromosomes Cancer. 2006. PMID: 16845659
Chronic myelogenous leukemia: molecular and cellular aspects.
Pasternak G, Hochhaus A, Schultheis B, Hehlmann R. Pasternak G, et al. Among authors: schultheis b. J Cancer Res Clin Oncol. 1998;124(12):643-60. doi: 10.1007/s004320050228. J Cancer Res Clin Oncol. 1998. PMID: 9879825 Review.
Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission. German CML Study Group and the UK MRC CML Study Group.
Hochhaus A, Reiter A, Saussele S, Reichert A, Emig M, Kaeda J, Schultheis B, Berger U, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Among authors: schultheis b. Blood. 2000 Jan 1;95(1):62-6. Blood. 2000. PMID: 10607685 Free article. Clinical Trial.
Zinc protoporphyrin, a useful parameter to address hyperferritinemia.
Metzgeroth G, Schultheis B, Dorn-Beineke A, Hehlmann R, Hastka J. Metzgeroth G, et al. Among authors: schultheis b. Ann Hematol. 2007 May;86(5):363-8. doi: 10.1007/s00277-007-0271-0. Epub 2007 Feb 28. Ann Hematol. 2007. PMID: 17333188 Clinical Trial.
84 results